Intrepida Bio Competitors and Similar CompaniesClear all
Curis's competitors and similar companies include ADC Therapeutics and Verseau Therapeutics.
 Curis Curis is a biotechnology company focused on the development and commercialization of innovative and effective drug candidates for the treatment of human cancers. |  ADC Therapeutics ADC Therapeutics is a biotechnology company that develops drug conjugates for the treatment of both solid and haematological cancers. |  Verseau Therapeutics Verseau Therapeutics is a company that develops macrophage checkpoint modulators designed to benefit patients with cancer, immune and inflammatory diseases. | |
Founding Date | Founding Date 2000 | Founding Date 2010 | Founding Date 2017 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Lexington, US HQ Lexington, US | Locations Epalinges, CH HQ London, GB New Providence, US | Locations Bedford, US HQ |
Employees | Employees 3144% decrease | Employees 1162% increase | Employees 6 |
Valuation ($) | Valuation ($) 29.4 m | Valuation ($) 295.9 m | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) $9.4m (FY, 2025) | Revenue (est.) $81.4m (FY, 2025) | Revenue (est.) N/A |
Net income | Net income ($7.6m) (FY, 2025) | Net income ($142.6m) (FY, 2025) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 526m | Total funding raised $ 50m |
For sources of this data, please see the company profile
View Company Profiles
ADC Therapeutics
HQ
Epalinges, CH
Employees
116↑ 2% increase
ADC Therapeutics is a biotechnology company that develops drug conjugates for the treatment of both solid and haematological cancers.
View companyVerseau Therapeutics
HQ
Bedford, US
Employees
6
Verseau Therapeutics is a company that develops macrophage checkpoint modulators designed to benefit patients with cancer, immune and inflammatory diseases.
View company